Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047428729> ?p ?o ?g. }
- W2047428729 endingPage "778" @default.
- W2047428729 startingPage "778" @default.
- W2047428729 abstract "Antibiotic stewardship is important in controlling resistance, adverse reactions, and cost. The literature regarding antibiotic use for eyelid surgery is lacking.To determine standard care and assess factors influencing antibiotic prescribing practices for eyelid surgery.A survey study was conducted from February 2, 2014, to March 24, 2014. The survey was distributed to 2397 oculoplastic surgeons in private and academic oculoplastic surgery practices in 43 countries. All surgeons were members of ophthalmic plastic and reconstructive surgery societies. Data were analyzed by geographic location. Linear regression was performed to quantify contributions to rates of prescribing postoperative antibiotics for routine eyelid surgical procedures.Rates of prescribing prophylactic intravenous, oral, and topical antibiotics as well as factors that influence surgeons' prescribing practices.A total of 782 responses were received from 2397 surgeons (average response rate, 36.7%; 2.5% margin of error) from 43 countries. Topical antibiotic use was common in all regions (85.2%). Perioperative intravenous antibiotic use was uncommon in all regions (13.5%). Geographic location was the greatest predictor of antibiotic prescribing practices (range, 2.9% in the United Kingdom to 86.7% in India; mean, 24%). Within Europe, Italy had the highest rate of antibiotic prescriptions for eyelid surgery (41.7%) and the United Kingdom had the lowest rate (2.9%.) In South America, Venezuela had the highest rate of antibiotic prescriptions for eyelid surgery (83.3%) and Chile had the lowest rate (0%). The practice locations that were associated with routinely prescribing postoperative oral antibiotics were India (odds ratio [OR], 15.83; 95% CI, 4.85-51.68; P < .001), Venezuela (OR, 13.47; 95% CI, 1.43-127.19; P = .02), and Southeast Asia (OR, 2.80; 95% CI, 1.15-6.84; P = .02). Conversely, practice location in the United Kingdom (OR, 0.048; 95% CI, 0.0063-0.37; P = .004), Australia and New Zealand (OR, 0.15; 95% CI, 0.033-0.67; P = .01), and the United States and Canada (OR, 0.41; 95% CI, 0.23-0.72; P = .002) were associated with decreased rates of postoperative oral antibiotic use. Surgeons' concern for allergic reactions was associated with decreased rates of prescribing antibiotics (OR, 0.34; 95% CI, 0.23-0.49; P < .001), while surgeons' concern for infection was associated with increased rates of prescribing antibiotics (OR 1.80; 95% CI, 1.45-2.23; P < .001).These results from members of ophthalmic plastic and reconstructive surgery societies confirm that antibiotic prescribing practices for routine eyelid surgical procedures vary widely throughout the world. No standard of care has been established that would require the routine use of postoperative prophylactic antibiotics following eyelid surgery." @default.
- W2047428729 created "2016-06-24" @default.
- W2047428729 creator A5000392843 @default.
- W2047428729 creator A5006374316 @default.
- W2047428729 creator A5026130928 @default.
- W2047428729 creator A5027256456 @default.
- W2047428729 creator A5029393091 @default.
- W2047428729 creator A5031063691 @default.
- W2047428729 creator A5042267117 @default.
- W2047428729 creator A5052317419 @default.
- W2047428729 creator A5057271918 @default.
- W2047428729 creator A5063713647 @default.
- W2047428729 creator A5065240223 @default.
- W2047428729 creator A5070169378 @default.
- W2047428729 creator A5073294639 @default.
- W2047428729 creator A5074787639 @default.
- W2047428729 creator A5083887766 @default.
- W2047428729 date "2015-07-01" @default.
- W2047428729 modified "2023-10-18" @default.
- W2047428729 title "Multinational Comparison of Prophylactic Antibiotic Use for Eyelid Surgery" @default.
- W2047428729 cites W129276799 @default.
- W2047428729 cites W1485491609 @default.
- W2047428729 cites W1601725634 @default.
- W2047428729 cites W1699287294 @default.
- W2047428729 cites W1963831904 @default.
- W2047428729 cites W2004748869 @default.
- W2047428729 cites W2032381830 @default.
- W2047428729 cites W2058104808 @default.
- W2047428729 cites W2066934759 @default.
- W2047428729 cites W2084300632 @default.
- W2047428729 cites W2086457694 @default.
- W2047428729 cites W2091239517 @default.
- W2047428729 cites W2107209401 @default.
- W2047428729 cites W2129085909 @default.
- W2047428729 cites W2135542480 @default.
- W2047428729 cites W2137076924 @default.
- W2047428729 cites W2162783822 @default.
- W2047428729 cites W2325410717 @default.
- W2047428729 cites W2326845225 @default.
- W2047428729 cites W2335003954 @default.
- W2047428729 cites W2404034713 @default.
- W2047428729 cites W329862877 @default.
- W2047428729 doi "https://doi.org/10.1001/jamaophthalmol.2015.0789" @default.
- W2047428729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25905446" @default.
- W2047428729 hasPublicationYear "2015" @default.
- W2047428729 type Work @default.
- W2047428729 sameAs 2047428729 @default.
- W2047428729 citedByCount "25" @default.
- W2047428729 countsByYear W20474287292015 @default.
- W2047428729 countsByYear W20474287292016 @default.
- W2047428729 countsByYear W20474287292017 @default.
- W2047428729 countsByYear W20474287292018 @default.
- W2047428729 countsByYear W20474287292019 @default.
- W2047428729 countsByYear W20474287292020 @default.
- W2047428729 countsByYear W20474287292021 @default.
- W2047428729 countsByYear W20474287292022 @default.
- W2047428729 countsByYear W20474287292023 @default.
- W2047428729 crossrefType "journal-article" @default.
- W2047428729 hasAuthorship W2047428729A5000392843 @default.
- W2047428729 hasAuthorship W2047428729A5006374316 @default.
- W2047428729 hasAuthorship W2047428729A5026130928 @default.
- W2047428729 hasAuthorship W2047428729A5027256456 @default.
- W2047428729 hasAuthorship W2047428729A5029393091 @default.
- W2047428729 hasAuthorship W2047428729A5031063691 @default.
- W2047428729 hasAuthorship W2047428729A5042267117 @default.
- W2047428729 hasAuthorship W2047428729A5052317419 @default.
- W2047428729 hasAuthorship W2047428729A5057271918 @default.
- W2047428729 hasAuthorship W2047428729A5063713647 @default.
- W2047428729 hasAuthorship W2047428729A5065240223 @default.
- W2047428729 hasAuthorship W2047428729A5070169378 @default.
- W2047428729 hasAuthorship W2047428729A5073294639 @default.
- W2047428729 hasAuthorship W2047428729A5074787639 @default.
- W2047428729 hasAuthorship W2047428729A5083887766 @default.
- W2047428729 hasConcept C137762411 @default.
- W2047428729 hasConcept C141071460 @default.
- W2047428729 hasConcept C2426938 @default.
- W2047428729 hasConcept C2781302119 @default.
- W2047428729 hasConcept C31174226 @default.
- W2047428729 hasConcept C501593827 @default.
- W2047428729 hasConcept C71924100 @default.
- W2047428729 hasConcept C86803240 @default.
- W2047428729 hasConcept C89423630 @default.
- W2047428729 hasConcept C98274493 @default.
- W2047428729 hasConceptScore W2047428729C137762411 @default.
- W2047428729 hasConceptScore W2047428729C141071460 @default.
- W2047428729 hasConceptScore W2047428729C2426938 @default.
- W2047428729 hasConceptScore W2047428729C2781302119 @default.
- W2047428729 hasConceptScore W2047428729C31174226 @default.
- W2047428729 hasConceptScore W2047428729C501593827 @default.
- W2047428729 hasConceptScore W2047428729C71924100 @default.
- W2047428729 hasConceptScore W2047428729C86803240 @default.
- W2047428729 hasConceptScore W2047428729C89423630 @default.
- W2047428729 hasConceptScore W2047428729C98274493 @default.
- W2047428729 hasIssue "7" @default.
- W2047428729 hasLocation W20474287291 @default.
- W2047428729 hasLocation W20474287292 @default.
- W2047428729 hasOpenAccess W2047428729 @default.
- W2047428729 hasPrimaryLocation W20474287291 @default.